by Kenjiro | Sep 25, 2025 | news
Leiden-based startup to accelerate development of RapiDetect™ CT/NG, a power-free, ambient temperature nucleic acid test to improve access to diagnostics worldwide. Leiden, The Netherlands – 25 September 2025. Rapidemic BV (“Rapidemic”), a molecular diagnostic company...
by salomi | Jan 20, 2025 | news
We are happy to announce a new collaboration between Rapidemic and the Maastricht UMC+, the national reference center for Chlamydia and Care And Public Health Research Institute (CAPHRI). The collaboration project is co-funded by PPP Subsidy awarded by Top Sector Life...
by Kenjiro | Oct 31, 2024 | news
At Rapidemic, we are committed to building the next generation of diagnostics for a healthier world. We’re honored to work with some of the most experienced organizations in global health, sharing our vision to make impactful advancements in diagnostics. We are...
by Kenjiro | Oct 9, 2024 | news
We were excited to showcase our first scientific poster at the 13th European Meeting on Molecular Diagnostics (EMMD) in Noordwijk, an event known for bringing together top experts and innovators in the molecular diagnostics field. EMMD provides an excellent platform...
by Kenjiro | Apr 26, 2024 | news
Big Announcement! We’re excited to be part of the start-ups ready to collaborate with healthcare provider Centre Hospitalier Universitaire de Nantes CHU de Nantes and industry leader TRONICO for the new Open Innovation Programme challenge. Together,...
by Kenjiro | Mar 13, 2024 | news
Early December 2024, Rapidemic joined the annual National Congress on SOA-HIV-Sex organized by SOAAIDS in Jaarbeurs Utrecht. On this day, clinicians, general pracititoners, medical microbiologists, patient organizations and policymakers meet to discuss...
